AndroScience Corporation, a biopharmaceutical company, engages in the research, development, and commercialization of a series of small molecules targeting androgen receptor (AR) dependent diseases. Its products include drug candidates for androgen-related disorders with a focus on dermatological indications and preclinical programs for systemic applications. The companyâs products also include products for acne, alopecia/male pattern baldness, and wound healing using topical based formulations; and products for prostate and other AR-related cancers, benign prostatic hyperplasia, and Kennedy's/neuron motor disease utilizing systemic based approaches.
